Big Data Analytics (BDA) has garnered significant attention in both academia and industries,
particularly in sectors such as healthcare, owing to the exponential growth of data and …

Nanomedicines are extensively explored for cancer therapy. By delivering drug molecules
more efficiently to pathological sites and by attenuating their accumulation in healthy organs …

The determination of tumor human epidermal growth factor receptor type 2 (HER2) status is
of increasing importance with the recent approval of more efficacious HER2-targeted …

Precision medicine and personalized medicine are two approaches to healthcare that aim to
tailor medical treatments and interventions to individual patients. These approaches are …

Radiotheranostics with 177Lu-PSMA have changed the treatment paradigm in patients with
prostate cancer, becoming the new standard in certain settings. Terbium-161 (161Tb) has …

This review article explores the dynamic field of radiopharmaceuticals, where innovative
developments arise from combining radioisotopes and pharmaceuticals, opening up …

Introduction In the last decade, two new radionuclide-based therapies, 223Radichloride and
radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA), have been …

Early use of targeted radionuclide therapy to eradicate tumor cell clusters and
micrometastases might offer cure. However, there is a need to select appropriate …

A paradigm shift is underway in cancer diagnosis and therapy using radioactivity-based
agents called radiopharmaceuticals. In the new strategy, diagnostic imaging measures the …

Colon adenocarcinoma (COAD) is among the most prevalent cancers worldwide, ranking as
the third most prevalent malignancy in incidence and mortality. The somatostatin receptor …